Hot Pursuit     04-May-24
Aurobindo Pharma's Rajasthan-based facility concludes US FDA audit with 7 observations
Aurobindo Pharma said that the United States Food and Drug Administration (US FDA) inspected the Unit-II, a formulation manufacturing facility of its wholly owned subsidiary Eugia Pharma Specialities that is situated at Bhiwadi, Rajasthan.

The inspection was conducted from 25th April 2024 to 3rd May 2024. The inspection closed with 7 observations.

"The observations are procedural in nature and will be responded to within the stipulated time,” Aurobindo Pharma said in a statement.

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

The drug maker reported 90.58% jump in consolidated net profit to Rs 936.29 crore on 13.82% rise in revenue from operations to Rs 7,271.23 crore in Q3 FY24 over Q3 FY23.

The scrip had lost 0.10% to end at Rs 1152.70 on the BSE on Friday.

Previous News
  Aurobindo Pharma Ltd spurts 3.21%
 ( Hot Pursuit - 18-May-24   13:05 )
  Aurobindo Pharma to table results
 ( Corporate News - 17-May-24   12:42 )
  Apitoria Pharma's Unit VII completes USFDA inspection
 ( Corporate News - 10-May-24   15:03 )
  Aurobindo Pharma's Rajasthan-based facility concludes US FDA audit with 7 observations
 ( Hot Pursuit - 04-May-24   14:38 )
  USFDA completes inspection of Eugia Pharma Specialities' Unit II
 ( Corporate News - 03-May-24   19:20 )
  Aurobindo Pharma update on acquisition of balance stake in Purple Bellflower, South Africa
 ( Corporate News - 02-May-24   14:58 )
  Aurobindo Pharma Ltd spurts 0.18%, gains for five straight sessions
 ( Hot Pursuit - 02-May-24   13:00 )
  Aurobindo Pharma completes disposal of business assets of Eugia US Manufacturing LLC
 ( Corporate News - 02-May-24   09:51 )
  Aurobindo Pharma Ltd rises for third consecutive session
 ( Hot Pursuit - 29-Apr-24   13:05 )
  Auro Pharma’s Andhra Pradesh facility gets 3 USFDA observations
 ( Hot Pursuit - 08-Apr-24   10:48 )
  Aurobindo Pharma reports accident in Unit 6 of Apitoria Pharma
 ( Corporate News - 08-Apr-24   10:36 )
Other Stories
  Kirloskar Ferrous Q4 PAT drops 81% YoY to Rs 18 cr
  18-May-24   16:00
  ZEEL reports turnaround Q4 numbers
  18-May-24   15:46
  NHPC Q4 PAT slides 18% to Rs 610 cr
  18-May-24   15:20
  Nestle India ends higher after public shareholders reject royalty hike proposal to Swiss parent
  18-May-24   15:12
  Sobha Q4 PAT drops 85% YoY to Rs 7 cr
  18-May-24   15:05
  Kirloskar Ferrous Industries Ltd leads losers in 'A' group
  18-May-24   15:00
  Vindhya Telelinks Ltd leads losers in 'B' group
  18-May-24   14:45
  Volumes soar at MTAR Technologies Ltd counter
  18-May-24   14:30
  Ashok Leyland Ltd up for third consecutive session
  18-May-24   13:05
  Zee Entertainment Enterprises Ltd spurts 4.37%
  18-May-24   13:05
Back Top